External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol 2007 Jul;106(1):215-20
Date
05/08/2007Pubmed ID
17482665DOI
10.1016/j.ygyno.2007.03.024Scopus ID
2-s2.0-34250159098 (requires institutional sign-in at Scopus site) 45 CitationsAbstract
PURPOSE: To determine if brachytherapy alone is adequate adjuvant local therapy in patients classified as intermediate risk after complete surgical staging for endometrioid adenocarcinoma.
METHODS: Between 1991 and 2004, 78 patients with FIGO stage IA-II (occult) disease meeting the eligibility criteria of GOG 99 received adjuvant radiotherapy following complete surgical staging (total abdominal hysterectomy and bilateral salpingo-oophorectomy, peritoneal cytology, and pelvic+/-para-aortic lymphadenectomy) for endometrioid adenocarcinoma at Washington University in St. Louis. Forty-two patients received postoperative vaginal brachytherapy alone and 36 received postoperative pelvis external radiotherapy (XRT) and vaginal brachytherapy. Fifty-two patients were classified as having high intermediate risk disease and 26 patients had low intermediate risk disease as defined by GOG 99. Median follow-up for all patients was 55 months.
RESULTS: The 5-year overall and disease-free survivals for all patients were 86% and 89%, respectively. There was no difference in 5-year disease-free survivals among patients classified as high intermediate risk vs. low intermediate risk (p=0.26) or in terms of radiation treatment received (p=0.95). There were two patients that had >grade 2 gastrointestinal complications, both were treated with external radiotherapy and vaginal brachytherapy.
CONCLUSIONS: Vaginal brachytherapy alone results in minimal morbidity and is adequate local therapy for intermediate risk patients with endometrioid adenocarcinoma after complete surgical staging.
Author List
Lin LL, Mutch DG, Rader JS, Powell MA, Grigsby PWAuthor
Janet Sue Rader MD Chair, Professor in the Obstetrics and Gynecology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AgedBrachytherapy
Carcinoma, Endometrioid
Disease-Free Survival
Endometrial Neoplasms
Female
Follow-Up Studies
Humans
Hysterectomy
Middle Aged
Neoplasm Staging
Ovariectomy
Proportional Hazards Models
Radiotherapy, Adjuvant
Retrospective Studies
Risk Factors
